miR-302b inhibits cancer-related inflammation by targeting ERBB4, IRF2 and CXCR4 in esophageal cancer

por Zhang, Mingxin, Zhang, Lingmin, Cui, Manli, Ye, Wenguang, Zhang, Pengjiang, Zhou, Suna, Wang, Jingjie
Publicado 2017